K
Katherine A. Hammer
Researcher at University of Western Australia
Publications - 94
Citations - 8121
Katherine A. Hammer is an academic researcher from University of Western Australia. The author has contributed to research in topics: Tea tree oil & Melaleuca alternifolia. The author has an hindex of 31, co-authored 78 publications receiving 7145 citations. Previous affiliations of Katherine A. Hammer include Cooperative Research Centre.
Papers
More filters
Journal ArticleDOI
Antimicrobial activity of essential oils and other plant extracts
TL;DR: The results of this study support the notion that plant essential oils and extracts may have a role as pharmaceuticals and preservatives.
Journal ArticleDOI
Melaleuca alternifolia (Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties
TL;DR: This review summarizes recent developments in understanding of the antimicrobial and anti-inflammatory activities of the tea tree oil and its components, as well as clinical efficacy.
Journal ArticleDOI
Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil.
TL;DR: The objective is to investigate the in vitro antifungal activity of the components of Melaleuca alternifolia (tea tree) oil to find out if it acts as a ‘spatially aggregating agent’ or ‘neutralizer’ to fungi.
Journal ArticleDOI
Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae
TL;DR: Data from this study support the hypothesis that tea tree oil and components exert their antifungal actions by altering membrane properties and compromising membrane-associated functions.
Journal ArticleDOI
Antimicrobial activity of commercial Olea europaea (olive) leaf extract
Aurelia N. Sudjana,Carla D’Orazio,Vanessa Ryan,Nooshin Rasool,Justin Ng,Nabilah Islam,Thomas V. Riley,Katherine A. Hammer +7 more
TL;DR: Investigation of the activity of a commercial extract derived from the leaves of Olea europaea (olive) against a wide range of microorganisms found it to be most active against Campylobacter jejuni, Helicobacter pylori and Staphylococcus aureus, with minimum inhibitory concentrations as low as 0.78% (v/v).